Microbiota Modulation of the Gut-Lung Axis in COVID-19

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (Unesp)-
Autor(es): dc.contributorUniversidade de São Paulo (USP)-
Autor(es): dc.creatorde Oliveira, Gislane Lelis Vilela [UNESP]-
Autor(es): dc.creatorOliveira, Camilla Narjara Simão-
Autor(es): dc.creatorPinzan, Camila Figueiredo-
Autor(es): dc.creatorde Salis, Larissa Vedovato Vilela [UNESP]-
Autor(es): dc.creatorCardoso, Cristina Ribeiro de Barros-
Data de aceite: dc.date.accessioned2022-02-22T00:51:48Z-
Data de disponibilização: dc.date.available2022-02-22T00:51:48Z-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2021-02-24-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.3389/fimmu.2021.635471-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/207919-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/207919-
Descrição: dc.descriptionCOVID-19 is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), and according to the World Health Organization (WHO), to date, SARS-CoV-2 has already infected more than 91.8 million people worldwide with 1,986,871 deaths. This virus affects mainly the respiratory system, but the gastrointestinal tract (GIT) is also a target, meanwhile SARS-CoV-2 was already detected in oesophagus, stomach, duodenum, rectum, and in fecal samples from COVID-19 patients. Prolonged GIT manifestations in COVID-19, mainly the diarrhea, were correlated with decreased richness and diversity of the gut microbiota, immune deregulation and delayed SARS-CoV-2 clearance. So, the bidirectional interactions between the respiratory mucosa and the gut microbiota, known as gut-lung axis, are supposed to be involved in the healthy or pathologic immune responses to SARS-CoV-2. In accordance, the intestinal dysbiosis is associated with increased mortality in other respiratory infections, due to an exacerbated inflammation and decreased regulatory or anti-inflammatory mechanisms in the lungs and in the gut, pointing to this important relationship between both mucosal compartments. Therefore, since the mucous membranes from the respiratory and gastrointestinal tracts are affected, in addition to dysbiosis and inflammation, it is plausible to assume that adjunctive therapies based on the modulation of the gut microbiota and re-establishment of eubiosis conditions could be an important therapeutic approach for constraining the harmful consequences of COVID-19. Then, in this review, we summarized studies showing the persistence of SARS-CoV-2 in the gastrointestinal system and the related digestive COVID-19 manifestations, in addition to the literature demonstrating nasopharyngeal, pulmonary and intestinal dysbiosis in COVID-19 patients. Lastly, we showed the potential beneficial role of probiotic administration in other respiratory infections, and discuss the possible role of probiotics as an adjunctive therapy in SARS-CoV-2 infection.-
Descrição: dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
Descrição: dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
Descrição: dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-
Descrição: dc.descriptionMicrobiology Program Institute of Biosciences Humanities and Exact Sciences São Paulo State University (UNESP)-
Descrição: dc.descriptionFood Engineering and Technology Department Institute of Biosciences Humanities and Exact Sciences São Paulo State University (UNESP)-
Descrição: dc.descriptionDepartment of Biochemistry and Immunology Ribeirão Preto Medical School University of São Paulo (USP)-
Descrição: dc.descriptionDepartment of Clinical Analysis Toxicology and Food Sciences School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo (USP)-
Descrição: dc.descriptionMicrobiology Program Institute of Biosciences Humanities and Exact Sciences São Paulo State University (UNESP)-
Descrição: dc.descriptionFood Engineering and Technology Department Institute of Biosciences Humanities and Exact Sciences São Paulo State University (UNESP)-
Descrição: dc.descriptionFAPESP: 2017/08651.1-
Descrição: dc.descriptionCNPq: 309583/2019-5-
Descrição: dc.descriptionCNPq: 310174/2016-3-
Descrição: dc.descriptionCAPES: Financial Code 001-
Idioma: dc.languageen-
Relação: dc.relationFrontiers in Immunology-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectgut-lung axis-
Palavras-chave: dc.subjectinflammation-
Palavras-chave: dc.subjectmicrobiota-
Palavras-chave: dc.subjectprobiotics-
Título: dc.titleMicrobiota Modulation of the Gut-Lung Axis in COVID-19-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.